Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$283,633
-$108,414 QoQ
Shares Held
2,245
-20.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,687
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meadow Creek Wealth Advisors LLC holds $8,288,807 across 9 Drug Manufacturers - General names. GILD ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,030 | $2,039,379 | |
| 2 | LLY |
ELI LILLY & Co
|
1,419 | $1,701,991 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,790 | $1,386,515 | |
| 4 | ABBV |
AbbVie Inc.
|
4,874 | $1,226,493 | |
| 5 | AMGN |
Amgen Inc
|
1,682 | $609,085 | |
| 6 | AZN |
Astrazeneca PLC
|
2,491 | $472,343 | |
| 7 | PFE |
Pfizer Inc
|
11,884 | $286,166 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,245 | $283,633 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,633 | 2,245 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $392,047 | 2,813 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $271,255 | 2,210 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $214,674 | 1,934 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $212,648 | 1,918 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||